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CK2 is a constitutively active Ser/Thr protein kinase deregulated in cancer and other pathologies, re-
sponsible for about the 20% of the human phosphoproteome. The holoenzyme is a complex composed of
two catalytic (α or α´) and two regulatory (β) subunits, with individual subunits also coexisting in the
cell. In the holoenzyme, CK2β is a substrate-dependent modulator of kinase activity. Therefore, a com-
prehensive characterization of CK2 cellular function should ﬁrstly address which substrates are phos-
phorylated exclusively when CK2β is present (class-III or beta-dependent substrates). However, current
experimental constrains limit this classiﬁcation to a few substrates. Here, we took advantage of motif-
based prediction and designed four linear patterns for predicting class-III behavior in sets of experi-
mentally determined CK2 substrates. Integrating high-throughput substrate prediction, functional clas-
siﬁcation and network analysis, our results suggest that beta-dependent phosphorylation might exert
particular regulatory roles in viral infection and biological processes/pathways like apoptosis, DNA repair
and RNA metabolism. It also pointed, that human beta-dependent substrates are mainly nuclear, a few of
them shuttling between nuclear and cytoplasmic compartments.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
CK2 is a constitutive and ubiquitous Ser/Thr protein kinase that
functions as a global regulator of cell survival often found de-
regulated in cancer and other complex diseases [1–4]. The CK2
consensus sequence, [pS/pT]-{P}-x-[E/D] or [pS/pT]-{P}-x-pS,
constitutes a small motif found so far in more than 300 experi-
mentally determined CK2 substrates among different organisms
and viral proteins [3]. Such promiscuity connects CK2-dependent
phosphorylation with key cellular biological processes and path-
ways involved in DNA repair [5], apoptosis [6], survival/prolifera-
tion [7], and viral infection [8].
The mammalian CK2 holoenzyme is a heterotetramer com-
posed of two catalytic (CK2α and/or CK2α′) and two regulatory
subunits (CK2β) with a α2-β2 stoichiometry (α2-β2, α′2-β2 or
α1α′1-β2) [9, 10]. The heterotetramer can dissociate under certain
conditions with evidences indicating the presence of individual
subunits [11]. The free catalytic monomers maintain its activity
against a range of substrates while the regulatory subunits might
display CK2-independent functions targeting DNA repair, cell cycleB.V. This is an open access article u
ez de Villavicencio-Díaz).
.and protein kinases as A-Raf, c-Mos and Chk1 [12]. In the ho-
loenzyme, CK2β is a substrate-dependent modulator of kinase
activity. In accordance, Pinna grouped the CK2 substrates in three
classes based on the subunit composition of active enzyme [4].
Class-I includes CK2 substrates modiﬁed either by CK2α or the
holoenzyme, poorly inﬂuenced by the CK2β subunit [13]. Class-II,
substrates such as calmodulin (CALM), phosphorylated by CK2α
alone with holoenzyme formation inhibiting kinase activity [14];
this regulatory effect is mitigated with the addition of polycationic
molecules (e.g., histones, polylysine and polyamines) [15]. Class-III
substrates are beta-dependent and their phosphorylation relies on
the integrity of the N terminal acidic loop of this subunit (se-
quence D55LEPDEELED64). This is true for Rev [16, 17] and eIF2β
[18] where electrostatic contacts between basic residues on the
substrates and the acidic loop enhance kinase-substrate binding.
The classiﬁcation of CK2 substrates based on active enzyme
subunit composition provides a framework for understanding the
regulatory function of CK2β subunit. However, few experiments
exist that functionally explore such classiﬁcation [17–23]; this
reﬂects practical limitations of elucidating kinase speciﬁcity. In
this regard, high-throughput methods provide an alternative to
traditional techniques for phosphosites identiﬁcation (e.g., ELISA
and phospho-speciﬁc antibodies). For instance, mass spectro-
metry-driven approaches ﬁgure at the most promising high-
throughput techniques with a subsequent increase in the use of innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in silico methodologies enclose motif-based identiﬁcation of
phosphorylation sites, structural information integration, integra-
tion of phosphorylation site structural context, phospho-clusters
modeling, integration of Protein–Protein Interaction Network
(PPIN) information, and multi-organisms prediction [24, 25]. Here,
we propose four linear patterns for identifying class-III CK2 sites.
These patterns were constructed manually based on literature and
database information describing well known class-III substrates.2. Materials and methods
2.1. CK2 substrates
The information of class-III CK2 substrates for motif design was
obtained by mining PubMed for functional relationships using
RLIMS-P [26] and Chilibot [27] text mining tools (Fig. S1). The
experimentally determined CK2 substrates were obtained from
PhosphoSitePlus resource [28] and the literature. The PhosphoSi-
tePlus information was extracted from the “Substrates of” CK2
protein, selecting both “CK2A1” and “CK2A2” entries (S1 File).
Literature information was gathered from the works of Meggio
and Pinna, 2003 [3] and Bian et al., 2013 [29] (S1 File) in the form
of phosphorylated peptides and UniProt entries, respectively. The
phosphorylated peptides reported by Pinna et al., were mapped to
UniProt identiﬁers using BLAST program, set to default values.
2.2. Class-III substrate prediction
The class-III substrates prediction (S2 File) was performed with
the ScanProsite tool [30] using the four designed linear patterns
and the UniProt identiﬁers obtained from PhosphoSitePlus re-
source and the literature (S1 File). The parameters selected for the
run were Option 3 (i.e., submit protein sequences and motifs to
scan them against each other) and match mode “greedy, overlap,
includes” as pattern options.
2.3. CK2 substrates three-dimensional structures
The PDB IDs corresponding to the predicted class-III substrates
were retrieved from UniProt (S3 File). The three-dimensional
structures of the experimentally determined and predicted class-
III substrates were retrieved from PDB database [31] (S3 File) for
interactive visualization and analysis using Chimera program [32].
The predicted class-III phosphopeptides were mapped to the PDBTable 1
In vitro CK2 class-III substrates retrieved from the literature.
Protein name (UniProt ID) Class-III sites/basic cluster
Rev S5GDSDEDLLKAVRLIKFLYQSNPPPN
(REV_HV1H3,
REV_HV1B1)
eIF2β (IF2B_HUMAN) S2GDEMIFDPTMSKKKKKKKK20
Nrg1 R152KQRTDPRNTLSDEE166
(NRG1_YEAST)
Fdx1b H56LIFEQHIFEKLEAITDEENDMLD
(ADX_HUMAN)
CFTR R1446VKLFPHRNSSKCKSKPQIAALK
(CFTR_HUMAN)
Olig2 (OLIG2_HUMAN) S84STSSAAASSTKKDKKQMTEPELQ
SIX1 (SIX1_HUMAN) R110VRRKFPLPRTIWDGEETSYCFK
Pdx1 (PDX1_HUMAN) R197RMKWKKEEDKKRGGGTAVG
En2 (HME2_CHICK) S150SDSDSSQAGSNAGNQPMLWPA
a Maximum number of amino acids in the substrate from CK2 consensus sequence (
For Nrg1, Olig2, SIX1, Pdx1, and En2 substrates the basic clusters were selected conside
b The position of the phosphosite Thr-71 refers to the mature protein and differs frsequences in FASTA format using PeptideMatch from PIR [33].
2.4. Sequence alignment
The sequence multiple alignment of Vpu sequences from HIV1
was performed using Clustal Omega program [34].
2.5. Functional classiﬁcation of predicted class-III substrates
The functional classiﬁcation of human predicted class-III sub-
strates was performed with DAVID [35], GeneCoDis [36] and
NetVenn [37] enrichment analysis tools based on GO biological
process, cellular component, cancer genes and/or KEGG pathway
annotations. The default parameters were selected and the sig-
niﬁcance level was set at 0.05 (Po0.05 considered signiﬁcant). For
DAVID analysis, the background list was selected as the CK2 sub-
strates identiﬁed in Bian et al. study. The protein function and the
sequence related annotations were extracted from UniProtKB [38]
and from the literature using Chilibot [27], RLIMS-P [26] and Go-
Pubmed [39] information retrieval and text mining tools.
2.6. Network analysis
Network representation and analysis were performed with
NetworkAnalyst tool [40] using the protein list functionality and
the predicted class-III substrates from Bian et al. dataset as the
input list. The network, 3509 nodes (193 seeds) and 8032 edges
obtained from InnateDB interaction dataset was trimmed to keep
only the seed nodes (class-III substrates predicted from Bian et al.
dataset) and their ﬁrst neighbors. The obtained network, 607
nodes (193 seeds) and 2801 edges, ﬁtted the recommended size
(200–2000 nodes) to avoid dense network and facilitate sub-
sequent analyses. Network nodes were functionally explored
based on KEGG pathway annotation and on their degree.3. Results and discussion
3.1. Linear pattern design for class-III substrate prediction
Pattern-matching is a useful approach for deciphering kinase–
substrates relationships at phosphosite level. Here, we designed
four linear patterns for matching CK2 class-III sites based on
available information of known class-III substrates. First, we used
text mining for extracting information on class-III substrates. As a
result, we found signiﬁcant mentions on: Rev protein from HIV1Maximum distancea
PEGTRQARRNRRRR44 29
8
7
LAYGLTDRSRLGCQICLTK98 12
EETEEE1474 13
QLRLKINSRERKR120 27
EKSRGVLREWYAHNPYPSPREKR155 5/28
GGGVAEPEQDCAVTSGEE234 30
WVYCTRYSDRPSSGPRSRKPKKK194 33
[pS/pT]-{P}-x-[E/D] or [pS/pT]-{P}-x-pS, underlined text) to a mapped basic cluster.
ring Rev's basic cluster position as reference.
om the position reported in UniProt where the residue corresponds to Thr-131.
Fig. 1. Surface representation of the three-dimensional structure of the human CK2
holoenzyme (PDB ID: 1JWH). Catalytic (CK2α) and regulatory (CK2β) subunits are
colored in yellow and purple, respectively. In one of the catalytic subunits, the
active site is occupied by the ATP analog adenylyl imidodiphosphate (AMPPNP). In
a close view, residues of two important functional regions, the basic cluster in CK2α
and the acid loop in CK2β, are denoted as balls-and-sticks in colors blue and red,
respectively. The minimal distance between the catalytic residue Asp-156 and the
acidic loop in CK2β (Asp-55 residue) is indicated with a dashed line (39.5 Å).
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died CK2 substrates (Table 1). We also detected the yeast tran-
scriptional regulator Nrg1 [41], the bovine ferredoxin Fdx1 [42],
the human transporter CFTR [43], the human homeoprotein SIX1
[19], the human transcription factor Olig2 [20], the human pan-
creas/duodenum homeobox protein 1 [21,22], and the chick
homeobox protein En2 [23] as beta-dependent substrates
(Table 1).
Second, we found relevant for holoenzyme-mediated phos-
phorylation the interaction between a cluster of basic residues in
Rev and eIF2β substrates (Rev: R38RNRRRR44 and eIF2β:
K14KKKKKK20) and the acidic loop of CK2β (Table 1). The basic
cluster in both substrates is located relatively far from the phos-
phorylatable residue (Table 1) and the acidic loop has been de-
scribed as the binding region for polybasic substances [14]. The
physical association of these determinants mitigates the intrinsic
down-regulatory function adjudicated to the acidic loop, allowing
the phosphorylation of the substrates [16]. For example, Rev and
CFTR-derived peptides lacking the basic cluster lose class-III be-
havior [16,17,43]. In addition, polycationic effectors inhibits ho-
loenzyme-dependent Rev phosphorylation indicating a competi-
tive mechanism in which binding of the acidic loop to a basic
cluster in Rev is imperative for substrate phosphorylation [16].
Similarly, polylysine has a negative effect on eIF2β phosphoryla-
tion. For instance, the addition of polylysine to the eIF2β 1-22
peptide, which contains the basic cluster, prevents peptide binding
to the CK2β acidic loop decreasing its afﬁnity for the holoenzyme
[18].
CK2 phosphorylates eIF2β protein at Ser-2 residue and Rev
protein at Ser-5 and Ser-8. In these substrates, the basic cluster is
positioned down-stream the consensus sequence to a maximum
distance of 8 and 29 amino acids, respectively (Table 1). Interest-
ingly, we found that the other selected class-III substrates also
contain a basic cluster relatively far from the phosphoacceptor site
at a maximum distance of 33 residues (Table 1). This basic cluster
primarily locates down-stream the modiﬁed residue(s). However,
for Fdx1, CFTR, SIX1 and Pdx1 proteins a basic cluster was found
up-stream the modiﬁed residue (Table 1) allowing us to speculate
that this determinant might act equally up-stream or down-
stream to regulate beta-dependent phosphorylation.
Since little information is available regarding CK2 substrates
structure and the phosphoacceptor sites spatial coordinates, we
considered only elements from the primary structure. In corre-
spondence, we designed two linear phosphorylation patterns
starting with the CK2 consensus sequence (positions 0–þ3). Next,
we included the minimum and the maximum number of amino
acids (x) allowed between CK2 consensus sequence and the acidic
cluster, ﬁve and 33, respectively. The lower limit is in agreement
with the minimum number of residues that in an extended con-
formation ﬁt the distance between CK2α active site and the acidic
loop in CK2β (Fig. 1). In this case we considered Cα-Cα distance as
3.8 Å [44] and the hydrogen bond distance between catalytic
Asp-156 and phosphorylable residue of 3.0 Å. The upper limit
was ﬁxed based on the maximum number of amino acids from
consensus sequence to the basic cluster in the validated class-III
substrates (Table 1). Finally, we included at least three basic re-
sidues to match the basic cluster (Table 1). This element ﬁts the
basic cluster of mentioned substrates except for Fdx1 and CFTR
proteins. The basic residues of these substrates are spaced irre-
gularly compared with the others from which the former pattern
can be deducted (Table 1).
The deﬁned linear phosphorylation patterns are:
1. [ST]-{P}-x-[ED]-x(5,33)-[KR]-x-[KR](2) or [ST]-{P}-x-[ED]-x
(5,33)-[KR](2)-x-[KR]
2. [ST]-{P}-x-S-x(5,33)-[KR]-x-[KR](2) or [ST]-{P}-x-S-x(5,33)-[KR](2)-x-[KR]
We also considered pattern variants where the basic cluster is
located up-stream the CK2 consensus sequence. The up-stream
linear patterns are:
3. [KR]-x-[KR](2)-x(5,33)-[ST]-{P}-x-[ED] or [KR](2)-x-[KR]-x
(5,33)-[ST]-{P}-x-[ED]
4. [KR]-x-[KR](2)-x(5,33)-[ST]-{P}-x-S or [KR](2)-x-[KR]-x(5,33)-
[ST]-{P}-x-S
3.2. CK2 class-III substrates prediction
A global classiﬁcation of CK2 substrates based on the subunit
composition of active enzyme is an ambitious and demanding
experimental task that will further increase our knowledge on this
kinase function. As previously reported, the use of in silico tools is
widely-accepted for kinase motif prediction and mapping of
phosphorylation sites [30,45]. Here, we applied phosphorylation-
patterns to predict class-III phosphorylation sites from sets of
experimentally determined CK2 substrates. As a result, those
proteins containing at least one match were considered tentative
CK2 class-III substrates (S2 File). Next, we functionally analyzed
the obtained results based on GO biological process, cellular
component and KEGG pathway annotations.
The class-III pattern-driven prediction was performed on 913
experimentally determined CK2 substrates, 1745 sites, retrieved
from PhosphoSitePlus database and the literature. This set in-
cludes data on CK2 phosphoacceptor sites for several organisms
such as human, mouse and rat (Table 2). The work reported by
Meggio and Pinna summarizes the information of phos-
phoacceptor sites of 33 different organisms and virus [3]. Here, we
selected 13 of them to match those represented in the Phospho-
SitePlus resource also considering the information available in the
literature relative to CK2 phosphorylation.
The prediction shows that 327 substrates, 467 sites, out of the
total matched the described phosphorylation patterns (Table 3).
Here, the number of substrates analyzed for prediction was 883
instead of 913 given that the ScanProSite tool eliminated 30 pro-
teins from which the corresponding UniProt entries were either
merged or deleted (Table 3). The rabbit, chicken, and African
clawed frog (Xenopus laevis) sets stood out with more than 50% of
Table 2
CK2 in vitro substrates analyzed for class-III site prediction.
Source Organism No. proteins No. phosphosites
PhosphoSitePlus Chicken 4 9
Cow 17 40
Human 199 406
Mouse 48 94
Rabbit 12 17
Rat 37 86
Dog 3 6
Meggio and Pinna[2] Bovine 9 14
Fruit ﬂy 7 15
Epstein-Barr virus 2 4
Chicken 2 4
Hepatitis delta virus 1 1
Human 78 135
HIV1 3 5
Mouse 9 12
Rabbit 7 13
Rat 11 22
Baker’s yeast 4 7
SV40 1 3
African clawed frog 2 3
Bian et al. [29] Human 575 986
Table 3
Class-III substrates and phosphosites predicted based on the designed linear pat-
terns across several organisms and viruses.
Organism No. proteins No. Class III
proteins (%)
No. phosphosites No. class
III sites
(%)
Human 734 274 (37) 1380 392 (28)
Mouse 50 16 (32) 98 25 (26)
Rat 39 11 (28) 90 16 (18)
Bovine 20 7 (35) 51 10 (20)
Rabbit 14 7 (50) 28 7 (25)
Fruit ﬂy 7 2 (29) 15 3 (20)
Chicken 4 2 (50) 11 4 (36)
Baker's yeast 4 1 (25) 7 1 (14)
HIV-1 3 2 (67) 5 3 (60)
Epstein-Barr
virus
2 2 (100) 4 2 (50)
African clawed
frog
2 1 (50) 3 1 (33)
Hepatitis delta
virus
1 1 (100) 1 1 (100)
SV40 1 1 (100) 3 2 (67)
Dog 2 – 6 –
Eliminated a 30 – 45 –
Total 913 327 1745 467
a CK2 substrates eliminated from the analysis by ScanProsite tool since the
corresponding UniProt entry was either merged or deleted from the database.
Fig. 2. Ribbon representation of CK2 holoenzyme substrate Rev helix–loop–helix
motif (PDB ID: 3LPH). The phosphosite Ser-8 is shown as balls-and-sticks. The
acidic residues in the vicinity of Ser-8 and those within the basic cluster are colored
in red and blue, respectively. The helixes and the loop of the HLH motif are depicted
in yellow and pink, respectively. The distances between Ser-8 phosphosite and the
ﬁrst (Arg-38, 47.1 Å) and last amino acid (Arg-44, 37.6 Å) of the basic cluster in the
substrate are represented in dashed lines.
Fig. 3. Ribbon representation of class-III CK2 substrates A) Fdx1 (PDB ID: 3N9Y)
and B) SIX1 (PDB ID: 4EGC). The phosphosite and the basic residues within the
basic cluster are shown as balls-and-sticks. The acidic residues in the vicinity of the
phosphosite and those within the basic cluster are colored in red and blue, re-
spectively. The sequence that contains the loop and the basic cluster is shown in
yellow. The distances between the phosphosite and the ﬁrst amino acid of the basic
cluster for each of the substrates are represented in dashed lines.
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other organisms such as human, mouse and fruit ﬂy the matches
represent around one third of the corresponding proteins (Ta-
ble 3). Nevertheless, a more systematic annotation of CK2 phos-
phoacceptor sites that provide comparable data among organisms
is needed.
3.3. Structural considerations
The sequence between the phosphosite(s) and the basic cluster
forms an extended region in eIF2β and a structural HLH (helix–
loop–helix) motif in Rev [16–18] (Fig. 2). Rev basic cluster localizes
at a greater distance compared with eIF2β (Table 1) but the ex-
istence of a HLH motif might bring closer these determinants due
to loop ﬂexibility (Fig. 2) [16,17]. The deletion of the loop in Rev
protein reduces holoenzyme phosphorylation efﬁciency [16]. This
illustrates the importance of considering information of proteinsecondary structure when analyzing beta-dependent phosphor-
ylation. However, experimental information is missing on known
class-III substrates that allow us to comprehensively describe the
vicinity of the phosphosites in a structural basis. For example,
among the other experimentally determined class-III substrates
only Fdx1 and SIX1 have structural information available; in both
cases the sequence between the phosphosite and the basic cluster
forms an extended region (Fig. 3).
Based on Rev and eIF2β information, we searched for the oc-
currence of phosphopeptides located in a HLH motif or in an ex-
tended region. First, we retrieved the PDB sequences in FASTA
format of the predicted substrates with associated PDB entries
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dicted phosphopeptides to the sequences identifying 29 substrates
(48 phosphopeptides) with at least one hit (in a total of 187
structures) (S3 File). Further sequence visualization and analysis
discarded 15 of the substrates since they had important missing
residues inside regions that matched the phosphopeptides (S3
File). From the 14 remaining substrates, two matched the HLH
motif (S2 Fig.), two the extended region (S2 Fig.) and the re-
maining ones showed other motifs (S3 File). Correspondingly, this
analysis pointed that in the 40% of the studied substrates; the
class-III phosphopeptides locate in a region of the protein where
the basic cluster may be closer to the phosphorylation site com-
pared with what is expected in primary sequence observation.
3.4. Intrinsic complexity of CK2 substrate classiﬁcation
CK2 substrate classiﬁcation is a simplistic view of a complex
regulatory process. Here, we provide two relevant examples on
calmodulin (CALM) and B23 CK2 substrates that illustrate the
complexity of class-III site prediction and that how a cautious in-
terpretation is needed when analyzing the prediction results.
CALM is a class-II substrate [46] for which phosphorylation is
enhanced by polybasic peptides such as polylysines and prota-
mines [15,47]. CK2 phosphorylates CALM in vitro with the catalytic
subunit modifying the Thr-79, Ser-81, Ser-101, and Thr-117 re-
sidues [15]. In the present study, these sites were used for class-III
prediction and no matches were expected. Conversely, we iden-
tiﬁed the Ser-101 residue, located in the Ca-binding loop III of the
protein [48], as a putative class-III site. To explain this result we
searched the literature and found a work by Arrigoni et al. 2004
that explored the CK2-dependent phosphorylation of these sites
using large synthetic peptides of the protein [15]. They concluded
that CK2 phosphorylation of different CALM peptides lacking the
C-terminal domain (essential for conferring class-II substrate be-
havior and polylysine dependency) occurs in the presence of ei-
ther the catalytic subunit or the holoenzyme. Noticeably, two of
these peptides, residues 93-106 and 54–106, included the Ser-101
phosphosite [15]. In this example, is made evident that the full-
length protein dictates the behavior of the different phosphosites
and that the classiﬁcation of the protein based on in vitro experi-
ments using peptides or in silico prediction could be misleading.
Other example that showcases classiﬁcation complexity is the
CK2-mediated phosphorylation of B23. This protein has been
previously regarded as a class-I CK2 substrate [13]. However, in a
recent work by Zanin et al. the authors tested the effect of the
beta-dependent phosphorylation inhibitor CK2-MCP peptide on
B23. Conversely, they observed a certain inhibitory effect indicat-
ing a possible dependence on the regulatory subunit. In agree-
ment, our analysis predicted the Ser-125 residue of B23 as a pu-
tative class-III site (Table 2). Although this ﬁnding supports the useTable 4
CK2 phosphorylated viral proteins and their tentative class-III sites.
Virus Protein
Name
CK2 PhosphoSitePlus Kinase assay substrat
(Class-III prediction)
HIV1 Rev Ser-5, Ser-8 protein, Rev 1-26 pept
Vpu Ser-52, Ser-56 protein, Vpu 32-81 pe
HIV2 Nef Ser-92 Nef87-96 (MDDVDSDD
Epstein-barr virus EBNA2 Ser-469, Ser-470 protein, EBNA2 462-47
peptide
BZLF1 Ser-167, Ser-173 protein
SV40 LT-AG Ser-106, Ser-111, Ser-112 LT-AG 106-119 (SEEMP
peptide
Hepatitis delta
virus
HDAg Ser-2 proteinof the designed patterns for capturing beta-dependent regulatory
effect further experiments are mandatory to comprehensively
describe B23 substrate behavior in vivo.
3.5. Class-III substrates functional classiﬁcation
3.5.1. Role of CK2 holoenzyme phosphorylation in viral infection
The relevance of CK2 in viral infection is accepted with the
enzyme interacting and/or phosphorylating both viral and in-
fectivity-related host proteins. CK2β subunit binds EBNA1 [49] and
IE63 [50] viral proteins while CK2α associates to NSI [51], pUL84
[52] and RIG-I (cellular viral infection defense) [53]. An example of
functional association between this kinase and viral proteins is the
induction of parvovirus capsid phosphorylation by NS1/CK2α
complex [51].
The Table 4 summarizes the identiﬁed class-III proteins/sites
relative to the four viruses selected for prediction and experi-
mental information of the kinase assay. It includes the Ser-5 and
Ser-8 phosphoacceptorsites of HIV-1 Rev protein used in pattern
design. Literature search shows that the identiﬁcation of CK2
phosphoacceptor sites among these proteins was carried out using
the holoenzyme and that no analysis of subunit contribution was
performed as it is the case for Rev protein (Table 4, S4 File). Thus,
in the absence of complementary information, pattern-matching
becomes a tool of choice guiding the detection of potential class-III
sites. For example, in our analysis Vpu, BZLF1, LT-AG, Nef, LT-Ag
and EBNA2 matched the designed patterns and were classiﬁed as
beta-dependent substrates. However, for Nef, LT-Ag and EBNA2
substrates, in particular, literature analysis does suggest that the
relevance of the basic cluster in the phosphorylation reaction
might be only evident in the full-length protein since derived
peptides lacking the basic determinant are phosphorylated by the
holoenzyme. This probably resembles the class-I behavior ob-
served in Ser-5 and Ser-8 phosphoacceptor sites in the context of
the Rev peptide [16].
Overall, our results for Vpu and BZLF1 proteins might serve to
speculate a functional relationship between these viral proteins
and CK2 beta-dependent phosphorylation. Hence, based on this
assumption, we searched the literature and found interesting
evidences connecting Vpu with CK2 beta-dependent phosphor-
ylation. For BZLF1 protein, literature information was insufﬁcient
for a further analysis (S4 File).
Vpu is a HIV1 viral protein involved in CD4 proteasomal de-
gradation and in the inhibition of protein transport from ER-Golgi
complex to the plasma membrane; functions regulated by CK2-
dependent phosphorylation of the Ser-52 and Ser-56 residues [62].
These phosphosites were characterized in vitro using CK2 ho-
loenzyme and Vpu recombinant protein and synthetic peptides
(Table 4) [55]. The studied peptides constitute variants of the hy-
drophilic C-terminal domain (residues 32–81) which besides thee type CK2 kinase assay References
ide Recombinant α and β subunits of human CK2. [16,17]
ptide Recombinant human CK2. [36,37]
DD) peptide Puriﬁed CK2 (bovine liver, lung, or brain) [56]
4 (FETTESPSSDEDY) Recombinant CK2. [57]
Recombinant CK2. [58–60]
SSDDEATAD) Puriﬁed CK2 (bovine liver, lung, or brain) [56]
No kinase assay. In vivo labeling and kinase
inhibitor experiments
[61]
Fig. 4. Biological processes and cellular components enriched in CK2 class-III
substrates predicted from Bian et al. dataset. All annotations are signiﬁcantly en-
riched (P valueo0.05).
T. Núñez de Villavicencio-Díaz et al. / Biochemistry and Biophysics Reports 4 (2015) 20–27 25CK2 consensus sequence contains a basic cluster (R34QRK37) at an
appropriate distance up-stream the phosphosites [54]. In corre-
spondence both sites were predicted as class-III.
The E47RAEDSGNESEG58 dodecapeptide is considered the major
determinant of Vpu CK2-mediated phosphorylation [63]. This is a
highly conserved sequence found in Vpu protein of different HIV1
strains [63]. To investigate the signiﬁcance of the basic cluster we
ran a BLAST search against UniProt database and identiﬁed 10 Vpu
proteins (reviewed status) sharing 100% of sequence identity to
the dodecapeptide (Fig. S3). The alignment of these 10 sequences
shows that the basic cluster is also well-conserved (Fig. S3). This
ﬁnding suggests that the acidic cluster might be a relevant reg-
ulatory element of CK2-mediated phosphorylation in Vpu. The
validation of this viral protein as a class-III substrate might provide
a strategy in which targeting of holoenzyme integrity will impair
protein function in HIV viral infection.
3.5.2. Functional classiﬁcation of human class-III substrates
Bian et al. performed a global screening of human CK2 sub-
strates where they identiﬁed 575 substrates of the kinase (988
sites) (Table 2, S1 File), a list enriched in spliceosomal proteins.
This experiment combined in vitro CK2 holoenzyme reaction and
immobilized proteome along with phosphoproteomics. The results
were reﬁned by ﬁltering the data based on in vivo phosphosites
information extracted from phosphorylation databases [29]. Im-
portantly, the authors used CK2 holoenzyme for kinase reaction
most likely marginalizing the phosphorylation of class-II sites [29].
Class-III prediction of Bian et al. substrates pointed out that 219
out of the 575 proteins might correspond to this category (Table 2).
The functional classiﬁcation of these putative class-III substrates
might serve to speculate, considering the predictive nature of this
approach, which biological processes and pathways linked to CK2
signaling might be targeted by class-III phosphorylation inhibitors.
As a result, the functional analysis relative to the background of
identiﬁed CK2 substrates (S5 File) indicated a signiﬁcant enrich-
ment of RNA processing biological process (P value¼0.003) and of
nuclear lumen subcellular localization (P value¼0.01) with pro-
teins from both the nucleolus (P value¼0.02) and the nucleoplasm
part (P value¼0.03). This suggests that the holoenzyme might
exert a key role regulating the function of nuclear located CK2
substrates that function on RNA processing events like RNA spli-
cing and mRNA processing. Likewise, selecting the human genome
as the background list (S5 File) indicated a marked enrichment of
processes related to RNA processing (P value¼6.31e10) and of
nuclear localization (P value¼8.48e63) (Fig. 4). Other enriched
biological processes and cellular components are regulation of
transcription (P value¼3.73e4), cell cycle (P value¼2.24e2),
apoptosis (P value¼0.007), cytoplasm (P value¼2.22e17), and
cytoskeleton (P value¼0.003) (Fig. 4).
A previous study by Filhol et al. analyzed the intracellular dy-
namic of CK2 subunits distribution using live-cell imaging [11].
The authors found that the holoenzyme is targeted to the cyto-
plasm and that binding to certain proteins such as FGF-2 enhances
its nuclear accumulation. In addition CK2 independent subunits
are imported to nucleus where they may associate to form the
holoenzyme or interact with nuclear proteins and mediate in-
dependent functions [11]. The subcellular location analysis (S5
File) shows an enrichmentof nuclear (137 proteins) and cyto-
plasmic (79 proteins) class-III predicted substrates with an overlap
of 62 proteins that localize to both compartments (Fig. 4). In cor-
respondence, we also studied the subcellular location of human
class-III substrates predicted from PhosphoSitePlus dataset. Simi-
larly, the substrate list was enriched in the nuclear (42 proteins)
and cytoplasm (33 proteins) locations with an overlap of 26 pro-
teins. Thus, the results suggest that beta-dependent phosphor-
ylation could modulate primarily the function of nuclear-locatedCK2 substrates. In addition, protein overlap points to a possible
link between cytoplasmic class-III substrates phosphorylation and
their redistribution to the nucleus.
The involvement of CK2 in DNA repair and its regulation has
been well-documented with the identiﬁcation for instance of
BRCA1, APC and P53 as binding partners and/or substrates of the
enzyme [64–66]. The biological process enrichment analysis (S5
File) supports a possible functional relationship between beta-
dependent phosphorylation and the response to DNA damage
stimulus and DNA repair. For example, the protein MDC1 (Med-
iator of DNA damage checkpoint protein 1), here predicted as a
class-III substrate, is a scaffold for the recruitment of DNA repair
and signal transduction proteins to damaged sites required for cell
cycle arrest. Its phosphorylation by CK2 promotes the assembly
and retention of the MRN complex to DSBs for the initiation of HR
repair [67].
RNA interference and down-regulation of CK2 abundance level
result in potent induction of apoptosis [68]. Here a total of 9 pro-
teins associated to apoptosis were predicted as class-III substrates
(DIDO1, CDK11A, PDCD4, CLSPN, FXR1, ZC3H8, DPF2, DDX41, and
PSMD2) (S5 File) Likewise, some of the predicted class-III sub-
strates were classiﬁed as cancer genes based on Futreal et al. 2004
(DEK, NUP98, PSIP1, MYH9, and HSP90AB1) [69] and Gene data-
base (CDC5L, DEK, MTDH, CLSPN, SLC4A1AP, RSF1, and PDCD4)
information (S5 File). For example, DEK is an oncogene with
chromosomal aberration in AML and the encoded protein is in-
volved in chromatin organization and in splice site selection dur-
ing mRNA processing. CK2-mediated phosphorylation of the
C-terminal domain modiﬁes DNA binding properties of DEK [70].
Furthermore, the mapping of predicted class-III substrates in
the human protein–protein interaction network (S5 File) situates
them as member of functional modules that correspond to in-
tracellular signaling pathways such as: cell cycle, RNA transport,
Wnt signaling pathway, and P53 signaling pathway (Fig. 5). We
also mapped the predicted substrates to modules associated to
pathways in cancer including prostate, pancreatic and lung cancer
and chronic myeloid leukemia. Finally, the network analysis also
pointed to the possible modulation of hub proteins including
HDAC1, NCL and ESR1 and of proteins essential for connectivity
Fig. 5. Protein–protein interaction network depicting the functional heterogeneity
of class-III substrates predicted from Bian et. al dataset (193 seed nodes) and of
their ﬁrst neighbors (414 nodes). Enriched pathways: cell cycle (pink, P
value¼1.64e11), RNA transport (green, P value¼2.41e11), Pathways in cancer
(red, P value¼9.98e05), Adherens junction (yellow, P value¼2.39e04), Wnt
signaling pathway (blue, P value¼0.005), and P53 signaling pathway (violet, P
value¼0.03). Node size is proportional to node degree.
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The four designed linear patterns aimed to assist CK2 beta-
dependent substrates prediction. The discrimination power of
these patterns relies on the recognition of a basic cluster at a
suitable distance from the phosphoacceptor site in the substrate.
Since the patterns utilized the CK2 consensus sequence for
matching substrates we performed the prediction of class-III
substrates on experimentally determined CK2 substrates to reduce
noise. As a result we obtained a list of 327 predicted class-III
substrates, 467 sites. The functional classiﬁcation of these sub-
strates indicated a role of beta-dependent regulation in viral in-
fection and biological processes and pathways such as apoptosis,
DNA repair and RNA metabolism. It also suggested that the human
substrates are primarily nuclear located with a number of them
also found in cytoplasm. A cautious interpretation of these results
is needed since this analysis derives from an in silico predictive
approach. Thus, future experiments are required to validate the
results of the prediction and the functional analysis.Author contributions
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